Soluble HLA: A review of the literature

Human Immunology

Volumn 59, Issue 7, 1998, Pages 387-403

  McDonald, John C ^a   Adamashvili, Irena ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN;

AUTOIMMUNE DISEASE; CHICKENPOX; DISEASE ASSOCIATION; HLA SYSTEM; HLA TYPING; IMMUNOMODULATION; PRIORITY JOURNAL; REVIEW; TUMOR IMMUNOLOGY;

HLA ANTIGENS; HUMANS; SOLUBILITY;

EID: 0031822376     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(98)00033-0     Document Type: Review

References (205)

1. Buelow R., Burlingham W.J., Clayberger C. Immunomodulation by soluble HLA class I. Transplantation. 59:(5):1995;649.
2. Gussow D., Ploegh H. Soluble class I antigens a conundrum with no solution? Immunol Today. 8:1987;220.
3. Calne R.Y., White H.J., Yoffa D.E., Maginn R.R., Binns R.M., Samuel J.R., Molina V.P. Observations of orthotopic liver transplantation in the pig. Br Med J. 2:(550):1967;478.
4. Calne R.Y., Sells R.A., Pena J.R., Davis D.R., Millard P.R., Herbertson B.M., Binns R.M., Davies D.A. Induction of immunological tolerance by porcine liver allografts. Nature. 223:(205):1969;472.
5. Van Rood J.J., van Leeuwan A., van Santen M.C.T. Anti HLA-A2 inhibitor in normal human sera. Nature. 226:1970;366.
6. Charlton R.K., Zmijewski C.M. Soluble HL-A7 antigen localization in the beta-lipoprotein fraction of human serum . Science. 170:(958):1970;636.
7. Schultz J.S., Shreffler D.C. Studies on the serum fraction containing soluble inhibitors of anti-HL-A sera. Transplantation. 13:(2):1972;186.
8. Aster R.H., Miskovich B.H., Rodey G.E. Histocompatibility antigens of human plasma Localization to the HLD-3 lipoprotein fraction . Transplantation. 16:(3):1973;205.
9. Bernier I., Dautigny A., Colombani J., Jolles P. Purification of HL-A antigens from the urine of diseased and healthy individuals. FEBS Lett. 45:(1):1974;308.
10. Zimmermann F.A., Butcher G.W., Davies H.S., Brons G., Kamada N., Turel O. Techniques for orthotopic liver transplantation in the rat and some studies of the immunologic responses to fully allogeneic liver grafts. Transplant Proc. 11:(1):1979;571.
11. Houssin D., Gigou M., Franco D., Bismuth H., Charpentier B., Lang P., Martin E. Specific transplantation tolerance induced by spontaneously tolerated liver allograft in inbred strains of rats. Transplantation. 29:(5):1980;418.
12. Houssin D., Charpentier B., Gugenheim J., Baudot P., Tamisier D., Lang P., Gigou M., Bismuth H. Spontaneous long-term acceptance of RT-1-incompatible liver allografts in inbred rats Analysis of the immune status . Transplantation. 36:(6):1983;615.
13. Kamada N., Brons G., Davies H.S. Fully allogeneic liver grafting in rats induces a state of systemic nonreactivity to donor transplantation antigens. Transplantation. 29:(5):1980;429.
14. Kamada N., Davies H.S., Roser B. Reversal of transplantation immunity by liver grafting. Nature. 292:(5826):1981;840.
15. Kamada N., Wight D.G. Antigen-specific immunosuppression induced by liver transplantation in the rat. Transplantation. 38:(3):1984;217.
16. Kobayashi E., Kamada N., Enosawa S., Toyama N., Walker N.I., Miyata M. Prevention by liver transplantation of the graft-versus-host reaction and allograft rejection in a rat model of small bowel transplantation. Transplantation. 57:(2):1994;177.
17. Kamada N. The immunology of experimental liver transplantation in the rat. Immunology. 55:(3):1985;369.
18. Kamada N., Shinomiya T. Clonal deletion as the mechanism of abrogation of immunological memory following liver grafting in rats. Immunology. 55:(1):1985;85.
19. Lucas Z.J. An assay for antibodies to histocompatibility antigens based on inhibition of radioiodine-labeled antibody binding. Transplantation. 10:(6):1970;512.
20. Foschi G.V., Manson L.A. Radioimmune assay for histocompatibility antigens. Nature. 225:(235):1970;853.
21. Miyakawa Y., Tanigaki N., Kreiter V.P., Moore G.E., Pressman D. Characterization of soluble substances in plasma carrying HL-A alloantigenic activity and HL-A common antigenic activity. Transplantation. 15:(3):1973;312.
22. Tanigaki N., Miyakawa Y., Yagi Y., Kreiter V.P., Pressman D. Radioiodinated soluble HL-A antigens HL-A alloantigenic characterization and use in radioimmunoassay . J Immunol Methods. 3:(2):1973;109.
23. Giphart M.J., Doyer E., Bruning J.W., Rood J.J. The application of radiolabelled HL-A antibodies in the detection of (soluble) transplantation antigens an alternative for the microcytotoxicity test . J Immunol Methods. 9:(2):1975;105.
24. Giphart M.J., Doyer E., Bruning J.W. A radioimmunoassay for soluble HLA-A antigens in human serum. Immunochemistry. 14:(2):1977;139.
25. Wilson B.S., Indiveri F., Pellegrino M.A., Ferrone S. Production and characterization of DR xenoantisera use for detection of serum DR antigens . J Immunol. 122:(5):1979;1967.
26. Barnstable C.J., Bodmer W.F., Brown G., Galfre G., Milstein C., Williams A.F., Ziegler A. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell. 14:(1):1978;9.
27. Parham P., Barnstable C.J., Bodmer W.F. Use of a monoclonal antibody (W6/32) in structural studies of HLA- A,B,C, antigens. J Immunol. 123:(1):1979;342.
28. Ferreira A., Revilla Y., Bootello A., Gonzalez-Porque P. Use of the ELISA to detect and quantify histocompatibility antigens and their subunits. J Immunol Methods. 65:(3):1983;373.
29. Russo C., Pellegrino M.A., Ferrone S. A Double-determinant immunoassay with monoclonal antibodies to the HLA-A, B, C complex. Transplant Proc. 15:1983;66.
30. Sakaguchi K., Ono R., Tsujisaki M., Richiardi P., Carbonara A., Park M.S., Tonai R., Terasaki P.I., Ferrone S. Anti-HLA-B7,B27,Bw42,Bw54,Bw55,Bw56,Bw67,Bw73 monoclonal antibodies specificity, idiotypes, and application for a double determinant immunoassay . Hum Immunol. 21:(3):1988;193.
31. Comuzio S., Puppo F., Ruzzenenti R., Orlandini A., Grillo F., Brenci S., Lanza L., Scudeletti M., Indiveri F. Simple ELISA method for the evaluation of soluble HLA class I antigens in human serum. J Clin Lab Anal. 5:(4):1991;278.
32. Doxiadis I., Westhoff U., Grosse-Wilde H. Quantification of soluble HLA class I gene products by an enzyme linked immunosorbent assay. Blut. 59:(5):1989;449.
33. Gelder F.B., McDonald J.C., Landreneau M.D., McMillan R.M., Aultman D.F. Identification, characterization, and quantitation of soluble HLA antigens in the circulation and peritoneal dialysate of renal patients. Ann Surg. 213:(6):1991;591.
34. Stevenson F.K., George A.J., Walters M.T., Hamblin T.J. Analysis of soluble HLA class II antigenic material in patients with immunological diseases using monoclonal antibodies. J Immunol Methods. 86:(2):1986;187.
35. Davies H.S., Pollard S.G., Calne R.Y. Soluble HLA antigens in the circulation of liver graft recipients. Transplantation. 47:(3):1989;524.
36. Kubens B.S., Passler M., Grosse-Wilde H. Segregation study of the soluble 39-kD HLA class I heavy chain. Hum Immunol. 40:(3):1994;247.
37. Reisfeld R.A., Allison J.P., Ferrone S., Pellegrino M.A., Poulik M.D. HL-A antigens in serum and urine isolation, characterization, and immunogenic properties . Transplant Proc. 8:(2):1976;173.
38. Vincent C., Revillard J.P., Betuel H. Purification of HLA antigens from urine. Transplantation. 22:(5):1976;500.
39. Allison J.P., Pellegrino M.A., Ferrone S., Callahan G.N., Reisfeld R.A. Biologic and chemical characterization of HLA antigens in human serum. J Immunol. 118:(3):1977;1004.
40. Dobbe L.M., Stam N.J., Neefjes J.J., Giphart M.J. Biochemical complexity of serum HLA class I molecules. Immunogenetics. 27:(3):1988;203.
41. Krangel M.S. Secretion of HLA-A and -B antigens via an alternative RNA splicing pathway. J Exp Med. 163:(5):1986;1173.
42. Krangel M.S. Two forms of HLA class I molecules in human plasma. Hum Immunol. 20:(2):1987;155.
43. Haga J.A., She J.X., Kao K.J. Biochemical characterization of 39-kDa class I histocompatibility antigen in plasma A secretable membrane protein derived from transmembrane domain deletion . J Biol Chem. 266:(6):1991;3695.
44. Hiraki D.D., See-Tho K., Filvaroff E., Krishnaswamy S., de Bello W., Taidi-Laskowski B., Grumet F.C. Bioengineered soluble HLA-B7 Genesis, characterization, and occurrence of dimerization . Hum Immunol. 40:(3):1994;235.
45. Villar L.M., Roy G., Lazaro I., Alvarez-Cermeno J.C., Gonzalez M., Brieva J.A., Del la Sen M.L., Leoro G., Bootello A., Gonzalez-Porque P. Detection of soluble class I molecules (non HLA-A or HLA-B) in serum, spleen membranes and lymphocytes in culture. Eur J Immunol. 19:(10):1989;1835.
46. Haga J.A., Riley W.J., Kao K.J. Effect of HLA phenotype and gender on expression of various forms of class I HLA in plasma. Hum Immunol. 32:(2):1991;79.
47. Pellegrino M.A., Ferrone S., Pellegrino A.G., Oh S.K., Reisfeld R.A. Evaluation of two sources of soluble HL-A antigens platelets and serum . Eur J Immunol. 4:(4):1974;250.
48. Billing R.J., Safani M., Peterson P. Soluble HLA antigens present in normal human serum. Tissue Antigens. 10:(2):1977;75.
49. Kao K.J. Plasma and platelet HLA in normal individuals quantitation by competitive enzyme-linked immunoassay . Blood. 70:(1):1987;282.
50. Kao K.J., Scornik J.C., Riley W.J., McQueen C.F. Association between HLA phenotype and HLA concentration in plasma or platelets. Hum Immunol. 21:(2):1988;115.
51. Zavazava N., Westphal E., Muller-Ruchholtz W. Characterization of soluble HLA molecules in sweat and quantitative HLA differences in serum of healthy individuals. J Immunogenet. 17:(6):1990;387.
52. Hagihara M., Shimura T., Yamamoto K., Takebe K., Munkhbat B., Tsuji K. Soluble HLA class I and class II in Japanese. Hum Immunol. 40:(3):1994;171.
53. Adamashvili I.M., Fraser P.M., McDonald J.C. Association of serum concentrations of soluble class I HLA with HLA allotypes. Transplantation. 61:(6):1996;984.
54. Weyand C.M., Jendro M., Goronzy J.J. Soluble HLA-DR molecules in patients with HLA class II versus class I associated disorders. Autoimmunity. 8:(4):1991;281.
55. Emerson S.G., Murphy D.B., Cone R.E. Selective turnover and shedding of H-2K and H-2D antigens is controlled by the major histocompatibility complex Implications for H-2-restricted recognition . J Exp Med. 152:(4):1980;783.
56. Liebert M., Aster R.H. Expression of HLA-B12 on platelets, on lymphocytes and in serum a quantitative study . Tissue Antigens. 9:(4):1977;199.
57. Robert M., Vincent C., Revillard J.P. Presence of HL-A antigens and beta2-microglobulin in tubular proteinuria. Transplantation. 18:(1):1974;89.
58. Vincent C., Revillard J.P. Characterization of molecules bearing HLA determinants in serum and urine. Transplant Proc. 11:(2):1979;1301.
59. McDonald J.C., Gelder F.B., Aultman D.F., Landreneau M.D., McMillan R.W., Singh I., Sorrells D., Liou W.H. HLA in human serum - quantitation of class I by enzyme immunoassay. Transplantation. 53:(2):1992;445.
60. Indiveri F., Wilson B.S., Natali P.G., Pellegrino M.A., Ferrone S. Immunogenicity of DR antigens isolated from body fluids. Transplant Proc. 12:(1):1980;121.
61. Koubek K. Serological Detection Of B-Cell ('Ia-Like') Antigens In serum of normal donor and in some sera of leukaemic patients. Folia Haematol Int Mag Klin Morphol Blutforsch. 109:(3):1982;408.
62. Pellegrino M.A., Russo C., Allison J.P. HLA antigens in serum. Methods Enzymol. 108:1984;614.
63. Westhoff U., Thinnes F.P., Gotz H., Grosse-Wilde H. Quantitation of soluble HLA class II molecules by an enzyme-linked immunosorbent assay. Vox Sang. 61:(2):1991;106.
64. Jendro M., Goronzy J.J., Weyand C.M. Structural and functional characterization of HLA-DR molecules circulating in the serum. Autoimmunity. 8:(4):1991;289.
65. McDonald J.C., Adamashvili I., Hayes J.M., Aultman D.F., Rhynes V.K., Gelder F.B. Soluble HLA class II concentrations in normal individuals and transplant recipients Comparison with soluble HLA class I concentrations . Transplantation. 58:(11):1994;1268.
66. Zavazava N., Wobst B., Ferstl R., Muller-Ruchholtz W. Soluble MHC class I molecules in human body fluids. J Clin Lab Anal. 8:(6):1994;432.
67. Lalezari P., Driscoll A.M. Ability of thrombocytes to acquire HLA specificity from plasma. Blood. 59:(1):1982;167.
68. Everett E.T., Kao K.J., Scornik J.C. Class I HLA molecules on human erythrocytes Quantitation and transfusion effects . Transplantation. 44:(1):1987;123.
69. Guencheva G., Scholz S., Schiessl B., Albert E.D. Soluble HLA antigens in normal human immunoglobulin preparations. Tissue Antigens. 19:(3):1982;198.
70. Grosse-Wilde H., Blasczyk R., Westhoff U. Soluble HLA class I and class II concentrations in commercial immunoglobulin preparations. Tissue Antigens. 39:(2):1992;74.
71. Santoso S., Kiefel V., Volz H., Mueller-Eckhardt C. Quantitation of soluble HLA class I antigen in human albumin and immunoglobulin preparations for intravenous use by solid-phase immunoassay. Vox Sang. 62:(1):1992;29.
72. Westhoff U., Grosse-Wilde H. Soluble HLA class I and class II concentrations in factor VIII and PCC preparations. Vox Sang. 68:(2):1995;73.
73. Kaveri S., Vassilev T., Hurez V., Lengagne R., Lefranc C., Cot S., Pouletty P., Glotz D., Kazatchkine M.D. Antibodies to a conserved region of HLA class I molecules, capable of modulating CD8 T cell-mediated function, are present in pooled normal immunoglobulin for therapeutic use. J Clin Invest. 97:(3):1996;865.
74. McLean I.L., Faed J.M., Milligan L.M., Adams D.D. Soluble HLA antigens not detected in human immunoglobulin preparations. Tissue Antigens. 22:(1):1983;59.
75. Inostroza J., Ferrada J., Navarrete C., Sorensen R.U. Soluble histocompatibility class I antigens and beta 2-microglobulin in pregnant females and cord blood samples. Hum Immunol. 54:(1):1997;63.
76. Ferreira A., Garcia Rodriguez M.C., Omenaca F., Jimenez A., Villar L.M., Gonzalez-Porque P., Fontan G. Soluble class I histocompatibility antigens (s-HLA) and beta 2-microglobulin at delivery. Clin Exp Immunol. 84:(1):1991;167.
77. Puri S., Shieh D.C., Canavan A., Kao K.J. Quantitation and characterization of plasma HLA in neonates of different gestational ages. Tissue Antigens. 42:(2):1993;67.
78. Reed E., Beer A.E., Hutcherson H., King D.W., Suciu-Foca N. The alloantibody response of pregnant women and its suppression by soluble HLA antigens and anti-idiotypic antibodies. J Reprod Immunol. 20:(2):1991;115.
79. Webb B.J., Bochan M.R., Montel A., Padilla L.M., Brahmi Z. The lack of NK cytotoxicity associated with fresh HUCB may be due to the presence of soluble HLA in the serum. Cell Immunol. 159:(2):1994;246.
80. Cosman D., Khoury G., Jay G. Three classes of mouse H-2 messenger RNA distinguished by analysis of cDNA clones. Nature. 295:(5844):1982;73.
81. Mellor A.L., Weiss E.H., Kress M., Jay G., Flavell R.A. A nonpolymorphic class I gene in the murine major histocompatibility complex. Cell. 36:(1):1984;139.
82. Maloy W.L., Coligan J.E., Barra Y., Jay G. Detection of a secreted form of the murine H-2 class I antigen with an antibody against its predicted carboxyl terminus. Proc Natl Acad Sci USA. 81:(4):1984;1216.
83. Krangel M.S., Pious D., Strominger J.L. Characterization of a B lymphoblastoid cell line mutant that secretes HLA-A2. J Immunol. 132:(6):1984;2984.
84. Krangel M.S. Unusual RNA splicing generates a secreted form of HLA-A2 in a mutagenized B lymphoblastoid cell line. Embo J. 4:(5):1985;1205.
85. Yang D., Le J. Targeted amplification of alternatively spliced transcripts of major histocompatibility complex class I heavy chain. J Immunol Methods. 176:(2):1994;265.
86. Huang F., Yamaguchi A., Tsuchiya N., Ikawa T., Tamura N., Virtala M.M., Granfors K., Yasaei P., Yu D.T. Induction of alternative splicing of HLA-B27 by bacterial invasion. Arthr Rheum. 40:(4):1997;694.
87. Ferreira A., Villar M.L., Alvarez Cermeno J.C., Revilla Y., Garcia Rodriguez M.C., Fontan G., Gonzalez-Porque P. Quantification of soluble serum HLA class I antigens in healthy volunteers and AIDS patients. Clin Chim Acta. 174:(2):1988;207.
88. Alvarez-Cermeno J.C., Casado C., Villar L.M., Ferreira A., Varela J.M., Dominguez M., Bootello A., Najera R., Gonzalez-Porque P. Soluble class 1 antigens (sHLA) in CSF and serum of patients with HIV infection. Acta Neurol Scand. 82:(1):1990;14.
89. Puppo F., Orlandini A., Ruzzenenti R., Comuzio S., Salamito A., Farinelli A., Stagnaro R., Indiveri F. HLA class I soluble antigen serum levels in HIV-positive subjects - correlation with cellular and serological parameters. Cancer Detect Prevent. 14:(3):1990;321.
90. Puppo F., Brenci S., Lanza L., Bosco O., Imro M.A., Scudeletti M., Indiveri F., Ferrone S. Increased level of serum HLA class I antigens in HIV infection Correlation with disease progression . Hum Immunol. 40:(4):1994;259.
91. Puppo F., Ruzzenenti R., Brenci S., Lanza L., Scudeletti M., Indiveri F. Major histocompatibility gene products and human immunodeficiency virus infection. J Lab Clin Med. 117:(2):1991;91.
92. Puppo F., Brenci S., Montinaro E., Lanza L., Contini P., Scudeletti M., Indiveri F. Inhibition of alloreactive cytotoxic T cell activity by HIV-positive sera potential role of circulating soluble HLA class I molecules . AIDS Res Hum Retroviruses. 10:(9):1994;1061.
93. Filaci G., Contini P., Brenci S., Lanza L., Scudeletti M., Indiveri F., Puppo F. Increased serum concentration of soluble HLA-DR antigens in HIV infection and following transplantation. Tissue Antigens. 46:(2):1995;117.
94. Alvarez-Cermeno J., Echevarria J.M., Villar L.M., Lazaro I., Bootello A., Gonzalez-Porque P. Soluble class I antigens in serum and CSF of patients with varicella-zoster virus meningitis. J Neurol Neurosurg Psychiatry. 52:(10):1989;1194.
95. Sakaguchi K., Koide N., Takenami T., Matsushima H., Takabatake H., Ferrone S., Tsuji T. Soluble HLA class I antigens in sera of patients with chronic hepatitis. Gastroenterol Jpn. 27:(2):1992;206.
96. Puppo F., Picciotto A., Brenci S., Varagona G., Scudeletti M., Ghio M., Balestra V., Celle G., Indiveri F. Behavior of soluble HLA class I antigens in patients with chronic hepatitis C during interferon therapy an early predictor marker of response? J Clin Immunol. 15:(4):1995;179.
97. Hagihara M., Shimura T., Takebe K., Munkhbat B., Hosoi K., Kagawa T., Watanabe N., Matsuzaki S., Yamamoto K., Sato K., Tsuji K. Serum concentrations of soluble HLA-class I and CD8 forms in patients with viral hepatic disorders. J Gastroenterol. 32:(3):1997;338.
98. Inostroza J., Munoz P., Espinoza R., Millaqueo L., Diaz P., Leiva L., Sorensen R. Quantitation of soluble HLA class I heterodimers and beta 2-microglobulin in patients with active pulmonary tuberculosis. Hum Immunol. 40:(3):1994;179.
99. Park C.W., Yun S.N., Yang C.W., Kim T.G., Han H., Choi E.J., Chang Y.S., Bang B.K. Serum and urine soluble HLA class I antigen concentrations are increased in patients with hemorrhagic fever with renal syndrome. Korean J Inter Med. 12:(1):1997;52.
100. Moore C., Ehlayel M., Inostroza J., Leiva L.E., Sorensen R.U. Elevated levels of soluble HLA class I (sHLA-I) in children with severe atopic dermatitis. Ann Allergy, Asthma, Immunol. 79:(2):1997;113.
101. Sandrin M.S., Henning M.M., Vaughan H.A., McKenzie I.F., Parish C.R. Serum Ia levels during tumor growth in mice and humans. J Natl Cancer Inst. 66:(2):1981;279.
102. Herlyn M., Lange B., Bennicelli J., Blaszczyk M., Guerry Dt, Koprowski H., Guerry D. Increased levels of circulating HLA-DR antigen in sera of patients with acute lymphoblastoid leukemia. Leuk Res. 8:(3):1984;323.
103. Shimura T., Hagihara M., Yamamoto K., Takebe K., Munkhbat B., Ogoshi K., Mitomi T., Nagamachi Y., Tsuji K. Quantification of serum-soluble HLA class I antigens in patients with gastric cancer. Hum Immunol. 40:(3):1994;183.
104. McMillan R.M., Gelder F.B., Zibari G.B., Aultman D.F., Adamashvili I., McDonald J.C. Soluble fraction of Class I human histocompatability leukocyte antigens in the serum of liver transplant recipients. Clin Transplan. 11:1997;98.
105. Stevenson F.K., Douglass W.A., Spellerberg M.B., Walters M.T., Cawley M.I. Soluble histocompatibility antigens in synovial fluids of patients with rheumatoid arthritis. Clin Exp Immunol. 80:(1):1990;32.
106. Adamashvili I.M., McDonald J.C., Fraser P.A., Milford E.L., Pressly T.A., Gelder F.B. Soluble class I HLA antigens in patients with rheumatoid arthritis and their families. J Rheumatol. 22:(6):1995;1025.
107. Hagihara M., Shimura T., Yamamoto K., Sujirachato K., Tsuji S., Yamamura M., Tsuji K. Clinical significance of serum soluble HLA class I antigens in systemic lupus erythematosus. Tokai J Exp Clin Med. 18:(1-2):1993;61.
108. Tsuchiya N., Shiota M., Yamaguchi A., Ito K. Elevated serum level of soluble HLA class I antigens in patients with systemic lupus erythematosus. Arthritis Rheum. 39:(5):1996;792.
109. Filaci G., Contini P., Brenci S., Gazzola P., Lanza L., Scudeletti M., Indiveri F., Mancardi G.L., Puppo F. Soluble HLA class I and class II molecule levels in serum and cerebrospinal fluid of multiple sclerosis patients. Hum Immunol. 54:(1):1997;54.
110. Saririan K., Wali A., Almeida R.P., Russo C. Increased serum HLA class I molecule levels in elderly human responders to influenza vaccination. Tissue Antigens. 42:(1):1993;9.
111. Capobianchi M.R., Ameglio F., Tosi R., Dolei A. Differences in the expression and release of DR, BR, and DQ molecules in human cells treated with recombinant interferon gamma comparison to other interferons . Hum Immunol. 13:(1):1985;1.
112. Le J., Hua J.C. Production of soluble HLA-class-I molecules by IFN-gamma-induced colon-adenocarcinoma cells. Int J Cancer. 60:(4):1995;576.
113. Burrone O.R., Milstein C. Control of HLA-A,B,C synthesis and expression in interferon-treated cells. Embo J. 1:(3):1982;345.
114. Fellous M., Nir U., Wallach D., Merlin G., Rubinstein M., Revel M. Interferon-dependent induction of mRNA for the major histocompatibility antigens in human fibroblasts and lymphoblastoid cells. Proc Natl Acad Sci USA. 79:(10):1982;3082.
115. Brieva J.A., Villar L.M., Leoro G., Alvarez-Cermeno J.C., Roldan E., Gonzalez-Porque P. Soluble HLA class I antigen secretion by normal lymphocytes relationship with cell activation and effect of interferon-gamma . Clin Exp Immunol. 82:(2):1990;390.
116. Zavazava N., Muller-Ruchholtz W. Quantitative and biochemical characterization of soluble HLA class I antigens shed by cultured human cells. Hum Immunol. 40:(3):1994;174.
117. Aulitzky W.E., Grosse-Wilde H., Westhoff U., Tilg H., Aulitzky W., Gastl G., Herold M., Huber C. Enhanced serum levels of soluble HLA class I molecules are induced by treatment with recombinant interferon-gamma (IFN-gamma). Clin Exp Immunol. 86:(2):1991;236.
118. Hillebrand K., Moritz T., Westhoff U., Niederle N., Grosse-Wilde H. Soluble HLA class I and beta-2-microglobulin plasma concentrations during interferon treatment of chronic myelogenous leukemia. Vox Sang. 67:(3):1994;310.
119. He X., Le J. Alternative splicing of HLA class I transcripts induced by IFN-gamma and TNF in fibroblasts release of soluble HLA class I heavy chain and an associate protein . Cell Immunol. 162:(1):1995;159.
120. Tsuji K., Kusama M., Nakatsuji T., Kato S. Biological significance of Ss (serum soluble) HLA-class I antigens in bone marrow transplantation. Tokai J Exp Clin Med. 10:(2-3):1985;169.
121. Thompson S., Wareham M., Pearson A.D., Sviland L., Turner G.A. A preliminary study of serum class II levels in healthy individuals and bone-marrow transplant patients. Clin Chim Acta. 185:(1):1989;45.
122. Westhoff U., Doxiadis I., Beelen D.W., Schaefer U.W., Grosse-Wilde H. Soluble HLA class I concentrations and GVHD after allogeneic marrow transplantation. Transplantation. 48:(5):1989;891.
123. Liem L.M., Koelman C.A., Doxiadis I.I., van Houwelingen J.C., Goulmy E., Claas F.H. Elevated serum HLA class I levels coincide with acute and chronic graft-versus-host disease. Bone Marrow Transplant. 20:(3):1997;227.
124. Puppo F., Brenci S., Ghio M., Bignardi D., Contini P., Bacigalupo A., Van Lint M.T., Scudeletti M., Ferrone S., Indiveri F. Serum HLA class I antigen levels in allogeneic bone marrow transplantation a possible marker of acute GVHD . Bone Marrow Transplantation. 17:(5):1996;753.
125. Zavazava N., Leimenstoll G., Muller-Ruchholtz W. Measurement of soluble MHC class I molecules in renal graft patients a noninvasive allograft monitor . J Clin Lab Anal. 4:(6):1990;426.
126. Rhynes V.K., McDonald J.C., Gelder F.B., Aultman D.F., Hayes J.M., McMillan R.W., Mancini M.C. Soluble HLA class I in the serum of transplant recipients. Ann Surg. 217:(5):1993;485.
127. Shimura T., Hagihara M., Yamamoto K., Takebe K., Munkhbat B., Tsuji K. Quantitation of soluble forms of HLA in kidney transplantation. Transplant Proc. 26:(4):1994;1891.
128. Yang C.W., Kim T.G., Kim Y.S., Han H., Chang Y.S., Yoon Y.S., Bang B.K. Serum soluble HLA class I antigen levels in hemodialysis patients and following renal transplantation. Am J Nephrol. 15:(4):1995;290.
129. Drouet M., Petit B., Peyronnet P., Aussel L., Venot J., Leroux-Robert C., Fauchet R. Soluble HLA Class I Antigens in Kidney Allograft Recipients. Transplant Proc. 27:(2):1995;1671.
130. Zavazava N., Bottcher H., Ruchholtz W.M. Soluble MHC class I antigens (sHLA) and anti-HLA antibodies in heart and kidney allograft recipients. Tissue Antigens. 42:(1):1993;20.
131. Puppo F., Pellicci R., Brenci S., Nocera A., Morelli N., Dardano G., Bertocchi M., Antonucci A., Ghio M., Scudeletti M., et al. HLA class-I-soluble antigen serum levels in liver transplantation A predictor marker of acute rejection . Hum Immunol. 40:(3):1994;166.
132. Abendroth D., Storck M., Techt B., Zavazava N. Analysis of the rejection markers tumor necrosis factor, ICAM-1, neopterin, interleukin-10, and soluble HLA in simultaneous pancreas and kidney transplantation with bladder drainage. Transplant Proc. 27:(6):1995;3114.
133. Molajoni E.R., F P., Brenci S., Scudeletti M., Cinti P., Alfani D., Indiveri F., Cortesini R. Serum HLA class I soluble antigens A marker of acute rejection following liver transplantation . Transplant Proc. 27:(1):1995;1155.
134. DeVito-Haynes L.D., Jankowska-Gan E., Heisey D.M., Cornwell R.D., Meyer K.C., Love R.B., Burlingham W.J. Soluble HLA class I in epithelial lining fluid of lung transplants associations with graft outcome . Hum Immunol. 52:(2):1997;95.
135. Rebmann V., Dornmair K., Grosse-Wilde H. Biochemical analysis of plasma-soluble invariant chains and their complex formation with soluble HLA-DR. Tissue Antigens. 49:(5):1997;438.
136. Pollard S.G., Davies H.S., Calne R.Y. Soluble class I antigen in human bile. Transplantation. 48:(4):1989;712.
137. Pollard S.G., Davies H.F., Calne R.Y. Peroperative appearance of serum class I antigen during liver transplantation. Transplantation. 49:(3):1990;659.
138. Zavazava N., Kraatz E., Gassel A.M., Muller-Ruchholtz W. Plasma MHC class I expression in cardiac graft patients Donor-specific soluble antigen in a presensitised graft patient . Transplant Proc. 23:(4):1991;2258.
139. DeVito-Haynes L.D., Jankowska-Gan E., Sollinger H.W., Knechtle S.J., Burlingham W.J. Monitoring of kidney and simultaneous pancreas-kidney transplantation rejection by release of donor-specific, soluble HLA class I. Hum Immunol. 40:(3):1994;191.
140. McDonald J.C., Adamashvili I., Zibari G.B., Aultman D.F., Mancini M.C., McMillan R.W., Gelder F.B. Serologic allogeneic chimerism. Transplantation. 64:(6):1997;865.
141. Goto S., Kamada N., Lord R., Kobayashi E., Enosawa S., Kim Y.L. Induction of natural chimerism after retransplantation of the liver in rats. Transplantation. 58:(11):1994;1230.
142. King D.W., Reed E., Suciu-Foca N. Complexes of soluble HLA antigens and anti-HLA autoantibodies in human sera possible role in maintenance of self-tolerance . Immunol Res. 8:(4):1989;249.
143. Hardy M.A., Suciu-Foca N., Reed E., Benvenisty A.I., Smith C., Rose E., Reemtsma K. Immunomodulation of kidney and heart transplants by anti-idiotypic antibodies. Ann Surg. 214:(4):1991;522.
144. Reed E.F., Hong B., Ho E., Harris P.E., Weinberger J., Suciu-Foca N. Monitoring of soluble HLA alloantigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant-associated coronary artery disease. Transplantation. 61:(4):1996;566.
145. Suciu-Foca N., Reed E., VD D.A., Ho E., Cohen D.J., Benvenisty A.L., McCabe R., Brensilver J.M., King D.W., Hardy M.A. Soluble HLA antigens, anti-HLA antibodies, and antiidiotypic antibodies in the circulation of renal transplant recipients. Transplantation. 51:(3):1991;593.
146. Suciu-Foca N., Ho E., King D.W., Yu Y.P., Yu-Kai S., Reed E., Cohen D., Brensilver J.M., McCabe R., Rose E., et al. Soluble HLA and anti-idiotypic antibodies in transplantation modulation of anti-HLA antibodies by soluble HLA antigens from the graft and anti-idiotypic antibodies in renal and cardiac allograft recipients . Transplant Proc. 23:(1 Pt 1):1991;295.
147. Piazza A., Torlone N., Valeri M., Poggi E., Monaco P.I., Provenzani L., Tisone G., Adorno D., Casciani C.U. Antidonor-HLA antibodies and soluble HLA antigens after kidney transplant. Transplant Proc. 25:(6):1993;3279.
148. Chauhan B., Phelan D.L., Marsh J.W., Mohanakumar T. Characterization of antiidiotypic antibodies to donor HLA that develop after liver transplantation. Transplantation. 56:(2):1993;443.
149. Mathew J.M., Shenoy S., Phelan D., Lowell J., Howard T., Mohanakumar T. Biochemical and immunological evaluation of donor-specific soluble HLA in the circulation of liver transplant recipients. Transplantation. 62:(2):1996;217.
150. Nimelstein S.H., Hotti A.R., Holman H.R. Transformation of histocompatibility immunogen into a tolerogen. J Exp Med. 138:(3):1973;723.
151. Law L.W., Appella E., Strober S., Wright P.W., Fischetti T. Soluble transplantation antigens Further studies of their tolerogenic properties . Transplantation. 18:(6):1974;487.
152. Priestley C.A., Dalchau R., Sawyer G.J., Fabre J.W. A detailed analysis of the potential of water-soluble classical class I MHC molecules for the suppression of kidney allograft rejection and in vitro cytotoxic T cell responses. Transplantation. 48:(6):1989;1031.
153. Goto S., Stepkowski S.M., Kahan B.D. Multiple injections of KCl-extracted donor-antigen in combination with a short course of cyclosporine therapy induces prolonged heart allograft survival in rats. Transplant Proc. 21:(2):1989;3300.
154. Sumimoto R., Kamada N. Specific suppression of allograft rejection by soluble class I antigen and complexes with monoclonal antibody. Transplantation. 50:(4):1990;678.
155. Zavazava N., Hausmann R., Muller-Ruchholtz W. Inhibition of anti-HLA-B7 alloreactive CTL by affinity-purified soluble HLA. Transplantation. 51:(4):1991;838.
156. Burlingham W.J., Fechner J.H., DeVito L.D., Sollinger H.W., Knechtle S.J., Grailer A.P. Human interleukin-2 and lymphoproliferative (T-helper cell) responses to soluble HLA class I antigens in vitro I.Specificity for polymorphic domains . Tissue Antigens. 42:(1):1993;35.
157. Krensky A.M. T cells in autoimmunity and allograft rejection. Kidney Int Suppl. 44:1994;S50.
158. Krensky A.M., Clayberger C. HLA-derived peptides as novel immunotherapeutics. Clin Immunol Immunopathol. 75:(2):1995;112.
159. Krensky A.M., Clayberger C. Human leukocyte antigen-derived peptides as novel immunosuppressives. Proc Assoc Am Physicians. 107:(1):1995;81.
160. + lymphocytes by soluble major histocompatibility complex class II-peptide complexes. J Clin Invest. 93:(4):1994;1361.
161. Pickl W.F., Majdic O., Fae I., Reuschel R., Holter W., Knapp W. The soluble pool of beta 2-microglobulin free HLA class I alpha-chains Qualitative and quantitative characterization . J Immunol. 151:(5):1993;2613.
162. Carbone E., Terrazzano G., Colonna M., Tuosto L., Piccolella E., Franksson L., Palazzolo G., Perez-Villar J.J., Fontana S., Karre K., Zappacosta S. Natural killer clones recognize specific soluble HLA class I molecules. Eur J Immunol. 26:(3):1996;683.
163. Zavazava N., Kronke M. Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes. Nat Med. 2:(9):1996;1005.
164. Smeraldi R.S., Fabio G., Bonara P., Villa M.G., Vanoli M., Pettenati C., Rugarli C., Zanussi C. MLC-specific suppressor T lymphocytes in man. I. Their induction in vitro by soluble HLA-DR antigens. J Immunol. 128:(3):1982;1394.
165. Claus R., Werner H., Schulze H.A., Walzel H., Friemel H. Are soluble monocyte-derived HLA class II molecules candidates for immunosuppressive activity? Immunol Lett. 26:(3):1990;203.
166. Claus R., Hausmann S., Zavazava N., Walzel H., Schulze H.A., Kohler H., Friemel H., Muller-Ruchholtz W. In vitro effects of solubilized HLA-DR-role in immunoregulation? Cell Immunol. 155:(2):1994;476.
167. Kress M., Cosman D., Khoury G., Jay G. Secretion of a transplantation-related antigen. Cell. 34:(1):1983;189.
168. McCluskey J., Boyd L.F., Highet P.F., Inman J., Margulies D.H. T cell activation by purified, soluble, class I MHC molecules Requirement for polyvalency . J Immunol. 141:(5):1988;1451.
169. Schneck J., Maloy W.L., Coligan J.E., Margulies D.H. Inhibition of an allospecific T cell hybridoma by soluble class I proteins and peptides estimation of the affinity of a T cell receptor for MHC . Cell. 56:(1):1989;47.
170. Grumet F.C., Krishnaswamy S., See-Tho K., Filvaroff E., Hiraki D.D. Soluble form of an HLA-B7 class I antigen specifically suppresses humoral alloimmunization. Hum Immunol. 40:(3):1994;228.
171. Hausmann R., Zavazava N., Steinmann J., Muller-Ruchholtz W. Interaction of papain-digested HLA class I molecules with human alloreactive cytotoxic T lymphocytes (CTL). Clin Exp Immunol. 91:(1):1993;183.
172. Pellegrino M.A., Indiveri F., Fagiolo U., Antonello A., Ferrone S. Immunogenicity of serum HLA antigens in allogeneic combinations. Transplantation. 33:(5):1982;530.
173. Meeusen E. The induction of cytotoxic T-cell responses with H-2 antigens shed from viable lymphocytes. Immunology. 61:(3):1987;321.
174. Kalmus H. The discrimination by the nose of the dog of individual human odors and in particular the odors of twins. Br J Animal Behavi. 3:1955;25.
175. Yamazaki K., Boyse E.A., Mike V., Thaler H.T., Mathieson B.J., Abbott J., Boyse J., Zayas Z.A., Thomas L. Control of mating preferences in mice by genes in the major histocompatibility complex. J Exp Med. 144:(5):1976;1324.
176. Yamazaki K., Yamaguchi M., Andrews P.W., Peake B., Boyse E.A. Mating preferences of F2 segregants of crosses between MHC-congenic mouse strains. Immunogenetics. 6:1978;253.
177. Yamazaki K., Yamaguchi M., Baranoski L., Bard J., Boyse E.A., Thomas L. Recognition among mice Evidence from the use of a Y-maze differentially scented by congenic mice of different major histocompatibility types . J Exper Medi. 150:(4):1979;755.
178. Yamaguchi M, Yamazaki K, Beauchamp GK, Bard J, Thomas L, Boyse EA: Distinctive urinary odors governed by the major histocompatibility locus of the mouse. Proceedings of the National Academy of Sciences of the United States of America 78(9):5817, 1981.
179. Yamazaki K., Beauchamp G.K., Thomas L., Boyse E.A. The hematopoietic system is a source of odorants that distinguish major histocompatibility types. J Exp Med. 162:(4):1985;1377.
180. Beauchamp G.K., Yamazaki K., Wysocki C.J., Slotnick B.M., Thomas L., Boyse E.A. Chemosensory recognition of mouse major histocompatibility types by another species. Proc Natl Acad Sci USA. 82:(12):1985;4186.
181. Gilbert A.N., Yamazaki K., Beauchamp G.K., Thomas L. Olfactory discrimination of mouse strains (Mus musculus) and major histocompatibility types by humans (Homo sapiens). J Cmop Psychol. 100:(3):1986;262.
182. Yamazaki K., Beauchamp G.K., Imai Y., Bard J., Phelan S.P., Thomas L., Boyse E.A. Odor types determined by the major histocompatibility complex in germfree mice. Proc Natl Acad Sci USA. 87:(21):1990;8413.
183. Beauchamp G.K., Yamazaki K., Curran M., Bard J., Boyse E.A. Fetal H-2 odortypes are evident in the urine of pregnant female mice. Immunogenetics. 39:(2):1994;109.
184. Yamazaki K, Beauchamp GK, Bard J, Thomas L, Boyse EA: Chemosensory recognition of phenotypes determined by the TIa and H-2K regions of chromosome 17 of the mouse. Proceedings of the National Academy of Sciences of the United States of America 79(24):7828, 1982.
185. Yamazaki K., Beauchamp G.K., Wysocki C.J., Bard J., Thomas L., Boyse E.A. Recognition of H-2 types in relation to the blocking of pregnancy in mice. Science. 221:(4606):1983;186.
186. Yamazaki K., Beauchamp G.K., Kupniewski D., Bard J., Thomas L., Boyse E.A. Familial imprinting determines H-2 selective mating preferences. Science. 240:(4857):1988;1331.
187. Singh P.B., Brown R.E., Roser B. MHC antigens in urine as olfactory recognition cues. Nature. 327:(6118):1987;161.
188. Brown R.E., Singh P.B., Roser B. The major histocompatibility complex and the chemosensory recognition of individuality in rats. Physiol Behav. 40:(1):1987;65.
189. Brown R.E., Roser B., Singh P.B. Class I and class II regions of the major histocompatibility complex both contribute to individual odors in congenic inbred strains of rats. Behav Genet. 19:(5):1989;659.
190. Singh P.B., Brown R.E., Roser B. Class I transplantation antigens in solution in body fluids and in the urine Individuality signals to the environment . J Exp Med. 168:(1):1988;195.
191. Tait B.D., Finlay R.I., Simons M.J. Serum HLA typing. Tissue Antigens. 17:(2):1981;129.
192. Pouletty P., Chang C., Kalil J., Atwood E., Ferrone S., Shimizu B., Howson W., Mazaheri R., Del Villano B., Grumet C. Typing of serum-soluble HLA-B27 antigen by ELISA. Tissue Antigens. 42:(1):1993;14.
193. Pouletty C., Mercier I., Glanville L., Tomavo N., Igoudin L., Pouletty P., Buelow R. Typing of a panel of soluble HLA class I antigens by enzyme-linked immunosorbent assay. Hum Immunol. 40:(3):1994;218.
194. Russo C., Fotino M., Carbonara A., Ferrone S. A double determinant immunoassay for HLA class I typing using serum as an antigen source. Hum Immunol. 19:(1):1987;69.
195. Grosse-Wilde H., Doxiadis I. Allotyping for HLA class I using plasma as antigen source. J Immunogenet. 16:(2):1989;149.
196. Sumitran-Karuppan S., Moller E. Specific inhibition of HLA class I and II antibodies by soluble antigens - a method for the identification of antibody specificity in sera from alloimmunized individuals. Transplantation. 58:(6):1994;713.
197. Sumitran-Karuppan S., Moller E. The use of magnetic beads coated with soluble HLA class I or class II proteins in antibody screening and for specificity determinations of donor-reactive antibodies. Transplantation. 61:(10):1996;1539.
198. Buelow R., Chiang T.R., Monteiro F., Cornejo M.C., Ellingson L., Claas F., Gaber O., Gelder F., Kotb M., Orosz C., et al. Soluble HLA antigens and ELISA - a new technology for crossmatch testing. Transplantation. 60:(12):1995;1594.
199. Emonds M.P., Claeys H., Volckaerts A., Dendievel J., Vermylen C. An EIA method on single donor solubilized HLA antigens for the identification of anti-HLA antibodies. Clini Lab Haematol. 19:(2):1997;129.
200. Buelow R., Mercier I., Glanville L., Regan J., Ellingson L., Janda G., Claas F., Colombe B., Gelder F., Grosse-Wilde H., et al. Detection of panel-reactive anti-HLA class I antibodies by enzyme-linked immunosorbent assay or lymphocytotoxicity Results of a blinded, controlled multicenter study . Hum Immunol. 44:(1):1995;1.
201. Regan J., Monteiro F., Speiser D., Kalil J., Pouletty P., Buelow R. Pretransplant rejection risk assessment through enzyme-linked immunosorbent assay analysis of anti-HLA class I antibodies. Am J Kidney Dis. 28:(1):1996;92.
202. Kerman R.H., Orosz C.G., Lorber M.I. Clinical relevance of anti-HLA antibodies pre and post transplant. Am J Medi Sci. 313:(5):1997;275.
203. Costa A.N., Scolari M.P., Iannelli S., Buscaroli A., GL D.A., Brando B., Indiveri F., Savi M., Borgnino L.C., DeSanctis L.B., Stefoni S., Bonomini V. The presence of posttransplant HLA-specific IgG antibodies detected by enzyme-linked immunosorbent assay correlates with specific rejection pathologies. Transplantation. 63:(1):1997;167.
204. Zachary A.A., Griffin J., Lucas D.P., Hart J.M., Leffell M.S. Evaluation of HLA antibodies with the PRA-STAT test An ELISA test using soluble HLA class I molecules . Transplantation. 60:(12):1995;1600.
205. Lucas D.P., Paparounis M.L., Myers L., Hart J.M., Zachary A.A. Detection of HLA class I-specific antibodies by the QuikScreen enzyme-linked immunosorbent assay. Clin Diag Lab Immunol. 4:(3):1997;252.